Interestingly, both bioinformatic analysis and Western blot showed that METTL14 was downregulated in HCC and was inversely related to SLC7A11 expression, which gave us a clue to hypothesize that METTL14 might negatively regulate SLC7A11. The gene discussed is SLC7A11; the disease is hepatocellular carcinoma.